Soulillou Jp

1.8k total citations
63 papers, 680 citations indexed

About

Soulillou Jp is a scholar working on Transplantation, Surgery and Immunology. According to data from OpenAlex, Soulillou Jp has authored 63 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Transplantation, 31 papers in Surgery and 16 papers in Immunology. Recurrent topics in Soulillou Jp's work include Renal Transplantation Outcomes and Treatments (34 papers), Organ Transplantation Techniques and Outcomes (22 papers) and Transplantation: Methods and Outcomes (12 papers). Soulillou Jp is often cited by papers focused on Renal Transplantation Outcomes and Treatments (34 papers), Organ Transplantation Techniques and Outcomes (22 papers) and Transplantation: Methods and Outcomes (12 papers). Soulillou Jp collaborates with scholars based in France, Canada and Switzerland. Soulillou Jp's co-authors include Y. Jacques, Diego Cantarovich, Magali Giral, Willem van Son, Neumayer Hh, Josep M. Grinyó, S A Sadek, Gunnar Tufveson, C. G. Groth and J.L. Rodicio and has published in prestigious journals such as Blood, American Journal of Kidney Diseases and Transplantation.

In The Last Decade

Soulillou Jp

60 papers receiving 652 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Soulillou Jp France 12 309 205 203 103 97 63 680
D. Scott Batty United States 11 469 1.5× 361 1.8× 514 2.5× 61 0.6× 83 0.9× 13 1.1k
Michelle Rashford United States 7 297 1.0× 142 0.7× 119 0.6× 226 2.2× 59 0.6× 10 640
Harold C. Sullivan United States 16 256 0.8× 195 1.0× 166 0.8× 198 1.9× 136 1.4× 43 828
Nöel Lh France 13 80 0.3× 97 0.5× 153 0.8× 30 0.3× 187 1.9× 31 670
Seung‐Ah Yahng South Korea 18 142 0.5× 65 0.3× 280 1.4× 193 1.9× 160 1.6× 88 1.0k
H Gerhartz Germany 12 57 0.2× 55 0.3× 161 0.8× 217 2.1× 100 1.0× 42 666
Anne Marie Maddox United States 12 57 0.2× 83 0.4× 83 0.4× 125 1.2× 139 1.4× 22 598
Pamela Bartels United States 7 128 0.4× 56 0.3× 199 1.0× 198 1.9× 194 2.0× 10 740
A. Loverre Italy 6 192 0.6× 202 1.0× 115 0.6× 474 4.6× 139 1.4× 7 906
Andrea Buonamano Italy 8 98 0.3× 97 0.5× 188 0.9× 186 1.8× 50 0.5× 8 510

Countries citing papers authored by Soulillou Jp

Since Specialization
Citations

This map shows the geographic impact of Soulillou Jp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soulillou Jp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soulillou Jp more than expected).

Fields of papers citing papers by Soulillou Jp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Soulillou Jp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soulillou Jp. The network helps show where Soulillou Jp may publish in the future.

Co-authorship network of co-authors of Soulillou Jp

This figure shows the co-authorship network connecting the top 25 collaborators of Soulillou Jp. A scholar is included among the top collaborators of Soulillou Jp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Soulillou Jp. Soulillou Jp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Behrend, Matthias, Josep M. Grinyó, Yves Vanrenterghem, et al.. (1999). Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial. Transplantation. 68(3). 391–396. 173 indexed citations
2.
Moore, Richard H., P. Wolf, D. Abendroth, et al.. (1999). Screening for basiliximab exposure–response relationships in renal allotransplantation. Clinical Transplantation. 13(1). 32–38. 35 indexed citations
3.
Rd, Guttmann & Soulillou Jp. (1998). Definitions of acute rejection and controlled clinical trials in the medical literature. American Journal of Kidney Diseases. 31(6). S3–S6. 8 indexed citations
4.
Cantarovich, Diego & Soulillou Jp. (1998). Efficacy Endpoints Conference on Acute Rejection in Kidney Transplantation: Review of the conference questionnaire. American Journal of Kidney Diseases. 31(6). S26–S30. 8 indexed citations
5.
Hourmant, Maryvonne, et al.. (1996). Correlations between clinical events and the detection of anti-HLA antibodies by Pra-Stat in kidney transplantation. Human Immunology. 47(1-2). 131–131. 1 indexed citations
6.
Thibaudeau, Karen, L Borche, Soulillou Jp, & Dominique Blanchard. (1996). Characterization of porcine platelet glycoproteins recognized by human natural "anti-gal" antibodies. Blood. 87(11). 4636–4642. 15 indexed citations
7.
Charreau, Béatrice, et al.. (1996). Xenoreactivity in the pig islet to human combination: feasibility of adenovirus-mediated gene transfer into pig islets.. PubMed. 28(2). 808–10. 4 indexed citations
8.
Cantarovich, Diego, et al.. (1994). Is the incidence of kidney rejection episodes higher in combined kidney/pancreas than in single kidney transplant patients?. PubMed. 26(2). 535–535. 1 indexed citations
9.
Jp, Soulillou. (1992). Bioreagents in allograft immunosuppression.. PubMed. 21. 373–86. 1 indexed citations
10.
Paineau, J, et al.. (1991). [Surgical experience with 50 transplantations of neoprene-occluded segmental pancreas. Technique and postoperative complications].. PubMed. 128(6-7). 275–80.
11.
Paineau, J, Diego Cantarovich, E Letessier, et al.. (1991). [Incidence of graft rejection after pancreas and kidney transplantation].. PubMed. 117(5-6). 357–63. 1 indexed citations
12.
Cantarovich, Diego, et al.. (1989). Anti-IL2 receptor monoclonal antibody (33B3.1) in prophylaxis of early kidney rejection in humans: a randomized trial versus rabbit antithymocyte globulin.. PubMed. 21(1 Pt 2). 1769–71. 13 indexed citations
13.
Cantarovich, Diego, Maryvonne Hourmant, Magali Giral, et al.. (1989). Treatment of acute kidney rejection episodes with monoclonal antibody directed against IL2 receptor: a pilot study.. PubMed. 21(1 Pt 2). 1785–6. 6 indexed citations
14.
Jp, Soulillou, et al.. (1988). Biochemical characterization and purification of HILDA, a human lymphokine active on eosinophils and bone marrow cells. Blood. 71(6). 1618–1623. 4 indexed citations
15.
Naulet, Jeanne, et al.. (1988). Biochemical characterization and purification of HILDA, a human lymphokine active on eosinophils and bone marrow cells. Blood. 71(6). 1618–1623. 49 indexed citations
16.
Hourmant, M, et al.. (1985). Comparison of three immunosuppressive regimens in kidney transplantation: a single-centre randomised study.. PubMed. 21. 982–6. 1 indexed citations
17.
Jp, Soulillou, et al.. (1985). Monoclonal antibodies against unglycosylated recombinant interleukin 2.. PubMed. 4(4). 319–30. 9 indexed citations
18.
Jf, Chatal, et al.. (1980). The respective roles of gallium 67 citrate scanning and diagnostic ultrasound in detecting suppurations in renal allograft recipients.. PubMed. 28(3). 155–9. 1 indexed citations
19.
Tanguy, Gaëlle, et al.. (1980). [Tertiary hyperparathyroidism following kidney transplants in man treated by parathyroidectomy and parathyroid autografts. A report on 8 cases (author's transl)].. PubMed. 117(11). 595–600. 1 indexed citations
20.
Buzelin, F, et al.. (1976). [Compensatory hypertrophy of the kidney. I. - Search for the existence of a renal inhibitory substance (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 24(6). 383–90. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026